🇮🇳IN
Sign In
BA

BAFNAPH

NSE

Bafna Pharmaceuticals Ltd

₹442.95

-9.00(-1.99%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

BAFNAPH valuation summary

Bafna Pharmaceuticals Ltd trades at 127.0 times trailing earnings. Return on equity is 12.3% and return on capital employed is 11.9%.

P/E127.0
ROE12.3%
ROCE11.9%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer